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Two Signals Are Necessary for Cell Proliferation
Induced by a Cytokine Receptor gp130:
Involvement of STAT3 in Anti-Apoptosis
Toshiyuki Fukada, Masahiko Hibi, Yojiro Yamanaka, with the tyrosine kinase janus kinases (JAKs), which
Mariko Takahashi-Tezuka, Yoshio Fujitani, are believed to play a major role in signal transduction
Takuya Yamaguchi, Koichi Nakajima, through the cytokine receptors (Ihle, 1995).
and Toshio Hirano IL-6 is a typical cytokine that exhibits various func-
Department of Molecular Oncology tions in the immune system, hepatocytes, and the ner-
Biomedical Research Center vous system (Haegeman et al., 1986; Zilberstein et al.,
Osaka University Medical School 1986; Hirano et al., 1986; Sehgal et al., 1989; Van Snick,
2-2 Yamada-oka 1990; Hirano, 1994). The receptor for IL-6 is composed
Suita, Osaka 565 of a ligand-binding a subunit and a signal-transducing
Japan component, gp130, which is also referred to as the b
subunit (Yamasaki et al., 1988; Taga et al., 1989; Hibi et
al., 1990). Both subunits of the IL-6 receptor belong to
the type I cytokine receptor superfamily, but only gp130
Summary has box1 and box2 in its cytoplasmic domain and is
capable of transmitting signals. gp130 is not only in-
gp130 is a common signal transducer for the interleu- volved in IL-6 signal transduction, but is also shared
kin-6-related cytokines. To delineate the gp130-medi- by the receptors for leukemia inhibitory factor, ciliary
ated growth signal, we established a series of pro-B neurotrophic factor, IL-11, oncostatin M, and cardio-
cell lines expressing chimeric receptors composed of trophin-1 (Ip et al., 1992; Yin et al., 1993; Hirano et al.,
the extracellular domain of the granulocyte colony- 1994; Pennica et al., 1995; Hibi et al., 1996). JAK1, JAK2,
stimulating factor receptor and the transmembrane and TYK2 have been shown to associate with gp130
and cytoplasmic domains of gp130. The second tyro- through its membrane-proximal region (Lutticken et al.,
sine (from the membrane) of gp130, which was re- 1994; Stahl et al., 1994). The binding of IL-6 to the a
quired for the tyrosine phosphorylation of SHP-2, its subunit induces the homodimerization of gp130 and
association with GRB2, and activation of a MAP ki- subsequently activates gp130-associated JAKs, possi-
nase, was essential for mitogenesis, but not for anti- bly by transphosphorylation (Murakami et al., 1993; Lut-
apoptosis. On the other hand, the tyrosine in the YXXQ ticken et al., 1994; Matsuda et al., 1994; Narazaki et al.,
motifs essential for STAT3 activation was required for 1994; Stahl et al., 1994). JAKs are thought to phosphory-
bcl-2 induction and anti-apoptosis. Furthermore, dom- late tyrosine residues on gp130 and on JAKs them-
inant-negative STAT3 inhibited anti-apoptosis. These selves. Phosphotyrosines on cytokine receptors have
data demonstrate that two distinct signals, mitogen-
been shown to recruit various src homology (SH2) do-
esis and anti-apoptosis, are required for gp130-
main–containing signal-transducing molecules to them,
induced cell growth and that STAT3 is involved in anti-
resulting in their tyrosine phosphorylation and activa-
apoptosis.
tion. Two such molecules have been found to be adap-
tors that bind the tyrosine-phosphorylated gp130. One
is the protein tyrosine phosphatase SHP-2, and theother
is the transcriptional factor STAT3 (signal transducerIntroduction
and activator of transcription 3) (Sadowski et al., 1993;
Akira et al., 1994; Stahl et al., 1995; Boulton et al., 1994).Cytokines play crucial roles in the immune system, he-
gp130 has six tyrosine residues in its cytoplasmic do-matopoiesis, inflammation, embryogenesis, and mor-
main, and the tyrosine phosphorylation of SHP-2 andphogenesis, and the abnormal expression of cytokines
that of STAT3 have been shown to depend on the sec-is involved in a variety of diseases. Their signals are
ond (from the membrane) and any one of the four tyro-transmitted through specific receptors on the cell mem-
sines (from third to sixth) in the carboxyl terminus (Stahlbrane. The receptors for cytokines such as the interleu-
et al., 1995; Yamanaka et al., 1996), respectively.kins (interleukin-2 [IL-2] through IL-7, IL-9, IL-11), the
SHP-2 (also referred as PTP1D, SHPTP-2, PTP2C, andcolony-stimulating factors (colony-stimulating factor
Syp) is a member of the protein tyrosine phosphatase[CSF], granulocyte CSF [G-CSF], granulocyte/macro-
family containing two SH2 domains (Adachi et al., 1996).phage CSF [GM-CSF]), hormones (growth hormone and
Among the members of this family, SHP-1 (also namedprolactin), and other biological mediators (cardiotrophin
SHPTP-1, SHP, HCP, and PTP1C) is thought to nega-1 and leptin, the gene product of obese) have amino acid
tively regulate receptor-mediated signals (Shen et al.,sequence homology that is characterized by conserved
1991; Plutzky et al., 1992; Yi et al., 1993; Matthews et al.,cysteines and WSXWS motifs in the extracellular do-
1992). In the case of the erythropoietin receptor (EpoR),main. Thus, these receptors are designated as members
SHP-1 binds phosphotyrosine (Y429) in the cytoplasmicof the type Icytokine receptor superfamily (Bazan, 1990).
domain of EpoRand inactivates the receptor-associatedThese receptors also have weak homology in the mem-
JAK2 (Klingmuller et al., 1995). In contrast, SHP-2 hasbrane-proximal region of their cytoplasmic domains,
a higher homology with the Drosophila tyrosine phos-termed box1 and box2. (Fukunagaet al., 1991; Murakami
et al., 1991). This region has been shown to associate phatase, Corkscrew (CSW) (Freeman et al., 1992), which
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acts downstream of the Drosophila tyrosine kinase Results
Torso (Perkins et al., 1992). Like CSW, SHP-2 has been
The Membrane-Proximal 68 Amino Acidshown to act downstream of tyrosine kinases such as
Region Is Sufficient for c-myc Induction,the epidermal growth factor (EGF) receptor, the fibro-
but Not for Cell Proliferationblast growth factor (FGF) receptor,and the insulin recep-
It has been reported previously that when human gp130tor (Noguchi et al., 1994; Li et al., 1994; Tang et al., 1995;
is expressed in the mouse pro-B cell line BAF-B03, IL-6Bennett et al., 1996). In the type I cytokine receptor
and the soluble a receptor bind gp130 and induce thymi-superfamily, SHP-2 has been reported to associate with
dine incorporation in the cells (Murakami et al., 1991).the prolactin receptor-JAK2 complex, and its SH2 do-
In that system it was concluded that the membrane-main and phosphatase activity are involved in the ex-
proximal 61 amino acid region, which contains the box1pression of the b-casein gene in response to prolactin
and box2 regions, is sufficient to induce transient(Ali et al., 1996). gp130 has a YSTV motif (known to be
growth. To address the question of whether this regionrecognized by SHP-2) at the second tyrosine, and upon
is sufficient to induce long-term cell proliferation, weligand binding SHP-2 has been shown to be tyrosine
constructed a series of chimeric receptors that consistphosphorylated in a manner dependent on the second
of the extracellular domain of the human G-CSF receptortyrosine of gp130 (Stahl et al., 1995).
(G-CSFR) and the transmembrane and cytoplasmic do-STATs were originally identified as transcriptional
mains of human gp130 (Figure 1) and transfected BAF-factors responsible for interferon-a- and interferon-
B03 cells, which do not express endogenous G-CSFRsg-dependent gene expression (Darnell et al., 1994). Ex-
(Fukunaga et al., 1991). The chimeric receptor systemperiments employing molecularly cloned STAT proteins
has been proven to generate a gp130-mediated signalrevealed that STAT is generally involved in cytokine sig-
in the mouse leukemia cell line M1 by inducing cellnal transduction (Ihle, 1996). All STAT molecules have
differentiation and growth arrest (Yamanaka et al., 1996).an SH2 domain, which recognize phosphotyrosine in a
We detected their expression by fluorescence-activatedspecific peptide motif. Among the STAT family mem-
cell sorting (FACS) using an anti–human G-CSFR anti-bers, IL-6 has been shown to induce the tyrosine phos-
body. All the transfectants established and used in thephorylation of STAT1 and STAT3, their nuclear translo-
present study had comparable numbers of receptor mol-cation, and their binding to a specific DNAelement (Akira
eculesexpressed onthe cellsurface (Figure 1). The pro-et al., 1994; Fujitani et al., 1994; Nakajima et al., 1995).
tein levels of the various chimeric receptors in theirThe tyrosine phosphorylation of STAT3 has been re-
transfectants were also comparable, as determined byported to require any one of four tyrosines in the car-
immunoblotting with anti-G-CSFR antibodies (data notboxy-terminal region of gp130. These tyrosines all have
shown).a glutamine at the third position away (YXXQ motifs)
BAF-B03 cells are IL-3 dependent and were main-(Stahl et al., 1995). Since each cytokine activates a rela-
tained in the presence of 10% conditioned medium fromtively specific species of STAT family proteins, STATs
WEHI3B as a source for IL-3. Without the starvationmay have a role in determining the specificity of the
of IL-3 (Figure 2A), cells expressing the G-68 chimericsignal transduction through a given receptor. In fact,
receptor, which contains 68 amino acids from the mem-each STAT contributes to a specific biological activity.
brane, incorporated [3H]thymidine to levels as high asMarrele/D-STAT has been shown to play a pivotal role
those incorporated by cells expressing the full-lengthin the regulation of the pair rule gene expression in
chimeric receptor G-277 (for further explanation of thisDrosophila early development (Yan et al., 1996). STAT1
terminology, see the legend to Figure 1). This result wasis known to be involved in the innate immunity elicited
consistent with the previous report (Murakami et al.,
by interferon-a and interferon-g (Meraz et al., 1996; Dur-
1991). However, when the transfectant cells were
bin et al., 1996). STAT4 is involved in the development
starved of IL-3, G-68 transfectant cells no longer incor-
of natural killer and T helper type 1 (Th1) cells in response
porated thymidine in response toG-CSF, whereas G-277
to IL-12 (Kaplan et al., 1996b; Thierfelder et al., 1996). transfectants did (Figure 2B). Although the data showed
STAT6 is involved in the transition of T lymphocytes that the G-68 chimeric receptor is not sufficient to com-
to Th2 and in immunoglobulin E (IgE) production and plete the cell growth signal, we observed c-myc mRNA
lymphocyte proliferation in response to IL-4 (Kaplan et induction in G-68 transfectants in response to G-CSF
al., 1996a; Shimoda et al., 1996; Takeda et al., 1996). In (Figure 2C).
IL-6 signaling, the activation of STAT3 has been found to
be essential for thedifferentiation of mouse M1 leukemia
cells (Yamanaka et al., 1996; Nakajima et al., 1996). How- The Amino Acid 69–133 Region Is Necessary to
ever, the role of STAT3 in the growth signal is unknown. Complete the Growth Signal and Is Required
In this study, we used chimeric receptors to show that for the Activation of SHP-2 and STAT3
in addition to the box1 and box2 regions, the tyrosine To find out which portions of gp130 are necessary to
residues in the carboxyl terminus were necessary for complete the growth signal, we established BAF-B03
gp130-mediated growth in BAF-B03 cells. Furthermore, transfectants expressing carboxy-terminal truncation
we demonstrated that the signal from the second tyro- mutants of the chimeric receptor and assessed their
sine and the STAT3 pathway from YXXQ motifs are both long-term growth. As shown in Figure 3A, truncation at
essential for the gp130-mediated cell growth. Moreover, the amino acid 133 residues from the membrane did not
STAT3 activation was shown to be linked with anti-apop- significantly affect cell growth. However, truncation at
amino acid 68 completely abolished G-CSF-dependenttotic signals through the induction of bcl-2.
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cell proliferation, suggesting that the amino acid 69–133
region is critical for full cell growth signal. This region
includes the second and third tyrosine residues (from
the membrane), which are known to be essential for the
tyrosine phosphorylation of SHP-2 and the activation of
STAT3. We evaluated the tyrosine phosphorylation of
STAT3 and SHP-2 in transfectants expressing truncation
mutants of the chimeric receptor (Figure 3B). Consistent
with previous reports (Stahl et al., 1995; Yamanaka et
al., 1996), gp130 truncated at amino acid 133 sustained
the tyrosine phosphorylation of both SHP-2 and STAT3
upon stimulation in BAF-B03 cells, but truncation to
amino acid 68 abolished their tyrosine phosphorylation.
The Signal from the Second Tyrosine Is Necessary
for the gp130-Mediated Mitogenesis
To assess the role of signals from the tyrosine residues
of gp130 in the growth signal, we constructed point
mutants in the context of the full-length chimeric recep-
tor (Figure 1) and established BAF-B03 transfectant cells
expressing them. As shown in Figure 4A, cells express-
ing G-Fall, in which all the tyrosine residues of gp130
were mutated to phenylalanines, did not proliferate in
response to G-CSF, but rather died within a few days.
The mutation of the second tyrosine (G-F2) also abol-
ished cell proliferation. However, G-F2 transfectants
survived for at least 4 days in the presence of G-CSF,
indicating that G-F2 could not generate a mitogenic
signal but could generate a survival signal in the cells.
The other single point mutations did not affect cell
growth or survival, indicating either that the other tyro-
sine residues could complement each other or that they
were not involved in the growth signal. The surrounding
amino acid sequence of the second tyrosine is YSTV,
which could be a docking site for SHP-2, so we exam-
ined whether the phosphorylated second tyrosine, but
not the other tyrosines, binds SHP-2. We prepared pep-
tides 15 amino acids in length containing phosphory-
lated or nonphosphorylated tyrosines (Y6 and P-Y6 con-
tain only 11 amino acid lengths because they are on the
carboxyl terminus) and mixed them with the lysates of
BAF-B03 G-277 transfectants. The peptide with a phos-
phorylated second tyrosine (P-Y2 in Figure 4B) precipi-
tated SHP-2 in the lysate of the cells, but neither the
peptide with a nonphosphorylated second tyrosine,
Figure 1. Structure and Expression of the G-CSFR–gp130 Chimeric the peptides phosphorylated on other tyrosines, nor the
Receptors in BAF-B03 Cells other nonphosphorylated peptides could precipitate
(Left) Structures of full-length, truncated, and tyrosine-mutated chi- SHP-2 from the cell lysates. None of the peptides could
meric receptors. Chimeric receptors are composed of the extracellu-
precipitate SHP-1, another SH2-containing tyrosinelar domain of G-CSFR (hatched boxes) and the transmembrane and
phosphatase (Figure 4B). These results indicate that thecytoplasmic domains of human gp130 (open boxes). The transmem-
second tyrosine is a unique tyrosine that binds SHP-2brane domain is indicated (TM). Vertical broken lines indicate box1
and box2 from the transmembrane domain. The chimeric receptors when phosphorylated and that its function cannot be
are named according to the last amino acid position from the mem- complemented by the other tyrosines on gp130. The
brane: full-length cytoplasmic domain (277 amino acids, G-277) and interaction between gp130 and SHP-2 in cells was ob-
receptors truncated at 195 (G-195), 133 (G-133), 68 (G-68), and 25 served when they were stimulated (Figure 4C), sug-
(G-25) amino acids from the membrane. Human gp130 has six tyro-
gesting that SHP-2 associates with gp130 upon stimula-sines (amino acids 42, 118, 126, 173, 262, and 274 from the mem-
tion. SHP-2 was reported to bind the adaptor moleculebrane; Y) in its cytoplasmic domain. In the G-CSFR-F1 (G-F1) mutant,
the first tyrosine in the cytoplasmic domain is replaced by phenylala-
nine (F). In the G-F2, G-F3, G-F4, G-F5, and G-F6 mutants, the
second, third, fourth, fifth, and sixth tyrosines are replaced by phe- tants. Cells were incubatedwith theanti-human G-CSFR (against the
nylalanines, respectively. In the G-133F2, G-133F3, and G-133F2/3 extracellular domain of G-CSFR) antibody and then with fluorescein
mutants, the second, third, or both second and third tyrosines are isothiocyanate (FITC)-conjugated goat anti–mouse IgG (open area).
replaced by phenylalanines. Closed areas indicate the fluorescence profile of the cells stained
(Right) Expression of the chimeric receptors on BAF-B03 transfec- with FITC-conjugated goat anti–mouse IgG alone (as the control).
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Figure 2. The Membrane-Proximal 68 Amino Acid Region Is Not
Sufficient to Induce Cell Proliferation
(A) Thymidine incorporation of transfectants without IL-3 starvation.
Prior to stimulation, BAF-B03 transfectant cells were maintained in
the presence of 10% FCS and 10% conditioned medium from
WEHI3B cells as a source of IL-3. Cells were washed with medium
lacking IL-3 and then cultured for 24 hr in the presence of various
concentrations of G-CSF. The cells were pulse labeled with
[3H]thymidine (0.5 mCi per well) for the last 10 hr, and the incorpo-
rated thymidine was measured. Results are indicated as percent-
ages of [3H]thymidine in the cells stimulated by G-CSF versus that
in the cells incubated with 10% conditioned medium (containing
IL-3) of WEHI3B cells.
(B) Thymidine incorporation with IL-3 starvation. The BAF-B03
transfectants were cultured in medium containing 10% FCS but
not IL-3 for 12 hr and then incubated in the presence of various
concentrations of G-CSF for 24 hr. Thymidine incorporation was
determined as described in (A).
(C) Northern blotting of c-myc. G-277, G-68, and mock cells were
stimulated by G-CSF for the indicated periods of time after IL-3
starvation. Total RNA was extracted from these cells, and 20 mg of
RNA was analyzed by Northern blotting with c-myc (left) and CHO-B
(as a control; right).
GRB2 through the phosphotyrosine(s) on SHP-2 upon induced MAP kinase activity as IL-3 did, and the muta-
tion of the second tyrosine in gp130 abolished the in-platelet-derived growth factor (PDGF) stimulation. We
assessed the interaction between SHP-2 and GRB2 duction of this enzyme activity (Figure 4F). These data
indicate that the signal from the second tyrosine is nec-upon gp130 stimulation. In G-277 transfectant cells,
G-CSF induced the association between SHP-2 and essary for gp130-mediated mitogenesis and suggest
that SHP-2, ERKs, or the cascade from SHP-2 to ERKsGRB2, as well as the tyrosine phosphorylation of SHP-2.
The mutation of the second tyrosine abolished either may play a role in mitogenic signaling.
the tyrosine phosphorylation of SHP-2 or the association
between SHP-2 and GRB2 (Figure 4D). Intriguingly, an- STAT3 Is Necessary for the gp130-Mediated
Survival Signalother tyrosine-phosphorylated protein whose molecular
mass is approximately 100 kDa was coprecipitated with It has already been established that any one of the four
tyrosines in the carboxyl terminus of gp130 can induceSHP-2, and it disappeared with the mutation of the sec-
ond tyrosine. GRB2 constitutively associated with Sos the tyrosine phosphorylation and activation of STAT3.
Therefore, single mutations in the context of the full-(Figure 4E), a GDP/GTP exchanger for Ras, as observed
in other cell lines. We further examined the activation length chimeric receptor could not abolish its tyrosine
phosphorylation (data not shown). The region containingof the Ras pathway by measuring the activity of the
mitogen-activated protein (MAP) kinase ERK2, a major 133 amino acids from the membrane was sufficient to
induce cell proliferation, and this region contains threetarget induced downstream of the Ras pathway. G-CSF
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more than 4 days, like the G-F2 transfectants in which
the second tyrosine was mutated in the context of the
full-length construct (Figure 4A). On the otherhand, both
G-133F3 and G-133F2/3 transfectant cells died within a
few days, suggesting that STAT3 activated through the
third tyrosine is critical for the cell survival signal. We
assayed DNA fragmentation (Figure 5D), which is an
indicator for apoptosis. In the presence of G-CSF,
G-277, G-133, G-133F2, or G-F2 (data not shown),
transfectants were not subject to apoptosis. In contrast,
G-133F3 and G-133F2/3 transfectants underwent
apoptosis in 24 hr, and cell cycle analysis showed that
they died in 1 day with the loss of DNA content in the
nucleus. These data clearly demonstrate that a signal
through the third tyrosine was critical for preventing
cell death. To show that a survival signal from the third
tyrosine does in fact involve STAT3, we utilized a domi-
nant-negative Stat3 gene that inhibits the activity of en-
dogenous STAT3 function. We previously demonstrated
that the STAT3F and STAT3D mutants, in which Tyr-
705, a phosphoacceptor site of STAT3, was mutated to
phenylalanine (STAT3F) and Glu-434 and Glu-435 of
the DNA-binding domain were mutated to alanines
(STAT3D), act specifically in a dominant-negative man-
ner (Nakajima et al., 1996). We transfected the G-277
transfectants with the expression vector for STAT3F or
STAT3D. Cells expressing either of the dominant-nega-
tive STAT3 proteins did not proliferate (Figure 6A) and
underwent cell death accompanied by DNA fragmenta-
tion (Figure 6B). We further examined the expression of
bcl-2, whose gene product is known to be involved in
preventing apoptosis, in cells expressing the series of
G-133 chimeric receptors or dominant-negative STAT3
proteins. As shown in Figure 7, the expression of bcl-2
was induced in G-277, G-133, and G-133F2 transfec-
tants, but was abolished in G-133F3, G-133F2/3, and
G-277 transfectants expressing STAT3F or STAT3D,
Figure 3. The Region Containing Amino Acids 69–133 Is Essential correlating with their susceptibility. These data show
for Long-Term Growth
that the activation of STAT3 is critical for the anti-apop-
(A) Cell proliferation of transfectants expressing the truncated chi-
totic signal.meric receptors. Transfectant cells (5 3 104) were cultured in 1 ml
of medium containing 100 ng/ml of G-CSF for 4 days. The number
Discussionof viable cells was then counted on the days indicated.
(B) Tyrosine phosphorylation of SHP-2 and STAT3. After cells were
starved of IL-3 for 12 hr, 1 3 107 cells were either stimulated (plus) Multiple Signals Are Generated from gp130
with G-CSF (100 ng/ml) for 15 min or left unstimulated (minus). for Cell Growth
SHP-2 or STAT3 was immunoprecipitated with anti-SHP-2 antibody
In the first part of this investigation, we identified theor anti-STAT3 antibody, respectively. Immunoprecipitates were sep-
regions of gp130 essential for cell growth. Usingarated on a 4%–20% gradient SDS–polyacrylamide gel and trans-
G-CSFR–gp130 chimeric receptors, we determined thatferred to membranes. The tyrosine phosphorylation and expression
were analyzed by blotting with anti-phosphotyrosine antibody and the membrane-proximal 68 amino acid region, con-
anti-SHP-2 antibody or anti-STAT3 antibody. taining box1 and box2, could induce thymidine incorpo-
ration in BAF-B03 cells without prior IL-3 starvation, but
with starvation of IL-3 thymidine incorporation was not
tyrosine residues, with only the third being a docking induced at all, although c-myc induction could still oc-
site for STAT3. To determine the role of STAT3 in cell cur. These data suggest the possibility that certain sig-
proliferation, we constructed point mutations of the sec- nals involved in the G1 to S transition are generated by
ond, third, or both tyrosine residues in the context of the 68 amino acid region. However, since the cells were
G-133. The mutation of either the second (Figure 1, not synchronized at the G0/G1 phase without the IL-3
G-133F2) or the third (Figure 1, G-133F3) tyrosine resi- starvation, it is difficult to interpret the results simply
due selectively abolished the tyrosine phosphorylation under this complicated condition. Under the synchro-
of either SHP-2 or STAT3 (Figure 5A). The G-133F2 nized condition, it is clear that the signals generated
transfectants did not proliferate (Figure 5B) and were from the membrane-proximal 133 amino acids of gp130
arrested at the S phase of the cell cycle without transi- are necessary and sufficient for full cell growth. We dem-
onstrated that at least two signals generated from thetion to the G2/M phase (Figure 5C), but survived for
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Figure 4. The Signal from the Second Tyrosine Is Necessary for gp130-Mediated Mitogenesis
(A) Cell proliferation of transfectants expressing the point-mutated chimeric receptors. Long-term growth of cells expressing point mutations
in the chimeric receptor was determined as described in Figure 3.
(B) The phosphorylated second tyrosine–containing peptide binds SHP-2. We mixed 1 3 107 cell lysates with the following biotinylated
peptides: Y2, NTSSTVQY*STVVHSG; Y3, STVVHSGY*RHQVPSV; Y4, GILPRQQY*FKQNCSQ; Y5, DEGMPKSY*LPQTVRQ; Y6, QTVRQGGY*MPQ;
or their tyrosine-phosphorylated peptides P-Y2, P-Y3, P-Y4, P-Y5, and P-Y6 (tyrosines marked with an asterisk are replaced by phosphotyro-
sines). The peptide-bound fractions were recovered with streptavidin–agarose, and the immunoprecipitates of anti-SHP-2 or anti-SHP-1
antibody (for control) were separated by SDS–PAGE. The transferred membranes were blotted with anti-SHP-2 or anti-SHP-1 antibody.
(C) SHP-2 interacts with gp130 in cells. HepG2 cells (1 3 107) were cultured in FCS-free medium for 6 hr and then stimulated with human IL-6
(100 ng/ml) for 15 min (plus) or left unstimulated (minus). gp130 or SHP-2 was immunoprecipitated with anti-gp130 antibody or anti-SHP-2
antibody, respectively. Immunoprecipitates were separated by SDS–PAGE and analyzed with anti-SHP-2 antibody.
(D) Tyrosine phosphorylation of SHP-2 correlates with the association of SHP-2 and GRB2. SHP-2 was immunoprecipitated from stimulated
(plus) or unstimulated cells (minus) with anti-SHP-2 antibody and blotted with anti-phosphotyrosine (top), anti-SHP-2 (middle), or anti-GRB2
antibodies (bottom). The arrow indicates the location of SHP-2 (top), and another tyrosine-phosphorylated protein (p100) was observed in the
SHP-2 immunoprecipitate of stimulated G-277 transfectants.
(E) The constitutive association of GRB2 and Sos. GRB2 and Sos were immunoprecipitated and blotted with anti-GRB2 antibody.
(F) The activation of ERK2 depends on the signal from the second tyrosine. Cells (1 3 107) were stimulated with either G-CSF (100 ng/ml) or
10% conditioned medium of WEHI3B cells or were incubated with medium alone (as a control) for 5, 15, and 30 min. The MAP kinase ERK2
was immunoprecipitated with anti-ERK2-specific antibody. The kinase reaction was carried out by incubating the precipitated fractions with
[g-32P]ATP and myelin basic protein (as a substrate) in the kinase buffer. The phosphorylated myelin basic protein was separated by SDS–PAGE
and subjected to autoradiography.
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Figure 5. The Second and Third Tyrosines Mediate Distinct Signals on the Basis of the G-133 Chimeric Constructs
(A) Tyrosine phosphorylation of SHP-2 and STAT3. The procedure was carried out as described in Figure 4.
(B) Cell proliferation. The procedure was carried out as described in Figure 3.
(C) Cell cycle analysis. Cells were synchronized by IL-3 starvation for 12 hr and then stimulated with either G-CSF (100 ng/ml) or left unstimulated
(NS). Cells were fixed at the indicated times and stained with propidium iodine, and their status in the cell cycle was analyzed by FACS. The
closed arrows indicate the G1/G0 phase and the open arrows indicate the G2/M phase of the cell cycle.
(D) DNA fragmentation. After IL-3 starvation, cells were stimulated with either G-CSF (100 ng/ml) or 10% conditioned medium from WEHI3B
cells (IL-3) or left unstimulated (NS) for 24 hr. Cells were then lysed, andchromosomal DNA was separated by TBE 2% agarose gel electrophoresis
as described in Experimental Procedures.
second and third tyrosines are necessary to complete IL-2 receptor (Kinoshita et al.,1995; Miyazaki et al., 1995;
Friedmann et al., 1996). This study of the cytokine recep-the growth signal.The chimeric receptors with the muta-
tion of the second tyrosine could exhibit a G1 to S phase tor family, however, establishes that two distinct tyro-
sine modules display independent signals necessary fortransition, but not an S to G2/M transition, indicating
that a signal(s) from the second tyrosine is necessary cell growth.
for the G2/M transition. The induction of a transition of
G1 to S, but not of S to G2/M, when BAF-B03 cells The Signal Elicited from the Second Tyrosine
Is Essential for Mitogenesis, and Thisexpressing the EGF receptor were stimulated by EGF
has been reported (Shibuya et al., 1992). Our present Process May Involve the SHP-2–MAP
Kinase Pathwayresults support the notion that multiple signals are in-
volved in the growth signal mediated through the type BAF-B03 cells expressing the chimeric receptor with the
mutation of the second tyrosine exhibited a transition ofI cytokine receptors, such as the IL-3 receptor and the
Immunity
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Figure 7. Northern Blotting of bcl-2
G-133, G-133F2, G-133F3, G-133F2/F3, G-277, G-277/STAT3F, and
G-277/STAT3D cells were stimulated by G-CSF for the indicated
periods of time following IL-3 starvation. Total RNA was extracted
from these cells, and 20 mg of RNA was analyzed by Northern blot-
ting with bcl-2 (left) and CHO-B (as a control; right).
Ras pathway. In addition to GRB2, another tyrosine-
phosphorylated protein (p100) was shown to associate
with SHP-2 when SHP-2 was tyrosine phosphorylated
(Figure 4D), and it might be involved in other signal
transduction cascades. The expression of a mutant
SHP-2 lacking the phosphatase activity has been shown
to suppress EGF, insulin, and FGF signaling (Noguchi
et al., 1994; Tang et al., 1995; Bennett et al., 1996),
but a mutation of Tyr-542 and Tyr-580 in the carboxylFigure 6. Dominant-Negative STAT3 Proteins Inhibit the Anti-Apop-
totic Signal terminus, including a GRB2-binding site, did not sup-
press the MAP kinase activation induced by EGF orG-277 cells were transfected with the expression vectors for STAT3F
and STAT3D, dominant-negative STAT3s in which either Tyr-705, a PDGF. SHP-2 has two more YXNX motifs in addition to
major phosphoacceptor site on STAT3, was mutated to phenylala- Tyr-542, the consensus sequence for GRB2 binding.
nine (G-277/STAT3F) or Glu-434 and Glu-435 of STAT3 in the DNA- These sites may participate in transmitting signal to the
binding domain were mutated to alanines (G-277/STAT3D), respec-
Ras pathway through GRB2. Recent genetic study oftively.
CSW, a homolog of SHP-2, in Drosophila revealed that(A) Cell proliferation. One representative clone for each construct
CSW acts downstream of the tyrosine kinases Torsowas subjected to cell proliferation determination as described in
Figure 3. and Sevenless, but did not determine whether it acts
(B) DNA fragmentation was analyzed as described in Figure 5. upstream of or parallel to Ras (Perkins et al., 1992;
Herbst et al., 1996; Raabe et al., 1996). To reveal the
true role of SHP-2 in gp130 signaling, it will be necessaryG1 to S phase without further progression in the cell
to examine the effect of expression of a phosphatasecycle, but survived for at least 4 days in the presence
inactive mutant or a mutant lacking all of the GRB2-of the ligand. These results are consistent with our previ-
binding sites on the cell growth.ous observation that the second tyrosine is essential
In addition to SHP-2, Shc, another adaptor moleculefor the gp130-mediated growth-enhancing signal in M1
in the Ras pathway, has been reported to be involvedleukemia cells (Nakajima et al., 1996). The same muta-
in the gp130-mediated growth signal in plasmacytomation abolished either the tyrosine phosphorylation of
cell lines (Kumar et al., 1994). We did not observe tyro-SHP-2 or the association between SHP-2 and the GRB2–
sine phosphorylation of Shc in BAF-B03 transfectantsSos complex, correlating with the loss of the activation
upon stimulation (data not shown). Thus, there might beof the MAP kinase ERK2, a major target of the Ras
cell type–specific adaptor molecules for gp130.pathway. Upon the stimulation of PDGF receptor, SHP-2
In the case of IL-3 and GM-CSF, which share thehas been reported to bind phosphorylated Tyr-1009 on
common b chain for the receptor with IL-5, truncationthe receptor, resulting in its phosphorylation at Tyr-542
of the carboxy-terminal region of b chain required forby the receptor kinase (Bennett et al., 1994). Then, GRB2
Ras activation could still elicit a signal inducing DNAcan bind to SHP-2 through the phosphorylated Tyr-542.
synthesis, but cells with the truncation underwentIn BAF-B03 transfectants, we observed that SHP-2 as-
apoptosis (Sato et al., 1993; Kinoshita et al., 1995). Insociated with gp130 upon gp130 stimulation (Figure 4C).
response to EGF activation, however, the SHP-2–MAPFurthermore, we detected the association between
kinase pathway, which might involveRas activation, wasSHP-2 and GRB2 only when SHP-2 was tyrosine phos-
shown to be necessary for cell cycle progression in NIHphorylated, and we observed that GRB2 constitutively
3T3 cells (Bennett et al., 1996). The activation of Ras byassociated with Sos, suggesting that SHP-2 plays a role
in transmitting a signal from the second tyrosine to the GRB2 was also shown to induce DNA synthesis and
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transformation (Lowenstein et al.,1992). In gp130 signal- in media containing horse serum without any other solu-
ble factors, suggesting that they constitutively generateing, the SHP-2–GRB2–Ras pathway may be involved in
mitogenesis, although this remains to be elucidated. an anti-apoptotic signal under these conditions and do
not need STAT3 for their survival but, rather, need it for
their differentiation. Alternatively, STAT3 may mediate
STAT3 Transmits an Anti-Apoptotic Signal different biological actions in synergy with unknown
Various STAT family proteins are reported to be acti- pathways or may induce the expression of a different
vated in response to cytokines. Their involvement in set of genes depending on the cell type involved.
growth signals remains unclear. In the case of the IL-2 Cell proliferation seems to involve a variety of compli-
receptor, a deletion of a region containing Tyr-392 and cated processes. In this report, we showed that at least
Tyr-510 of the common b chain of the IL-2 receptor two signals, a mitogenic signal and an anti-apoptotic
abolished the tyrosine phosphorylation and activation signal, are critical for the cell proliferation induced by
of STAT5, but cells with the mutated receptor could still the cytokine receptor gp130. This model may be applied
grow in response to IL-2 (Fujii et al., 1995). However, to the signal transduction of other cytokine receptors.
for maximal proliferation it was shown that the activation
of STAT5 through these tyrosines was necessary (Fried- Experimental Procedures
mann et al., 1996). A mutant erythropoietin (Epo) recep-
Cell Culture, Transfection, and Biological Reagentstor that lacks Tyr-343 and Tyr-401 has been shown to
BAF-B03 cells were maintained in RPMI medium (GIBCO) supple-reduce the activation of STAT5 as well as its mediated
mented with 10% fetal calf serum (FCS), 10% conditioned mediumcell growth (Damen et al., 1995; Gobert et al., 1996). In
from WEHI3B cells as a source of IL-3, 100 U/ml penicillin, and 100the case of the IL-3/GM-CSFR, a correlation between
mg/ml streptomycin. HepG2 cells were maintained in Dulbecco’s
the activation of STAT5 and the mitogenic signal was modified Eagle’s medium (GIBCO) supplemented with 10% FCS
observed. Furthermore, the expression of a STAT5 mu- and antibiotics. Transfection was performed by the electroporation
method using a Gene Pulser (Bio-Rad). We cotransfected 50 mgtant truncated in its carboxyl terminus partially blocked
of the expression vectors for either the chimeric receptors or thethe mitogenic signal (Mui et al., 1996). In addition, there
dominant-negative Stat3 genes (Stat3D and Stat3F) with 5 mg ofare several reports suggesting that STAT proteins are
pSV2-neo or pMIK-Hyg, respectively. Transfectants were selected
involved in the cell growth signal. STAT3 or STAT5 and with 1 mg/ml G418 or 200 mg/ml hygromycin for pSV2-neo or pMIK-
STAT6 have been reported to be activated in v-src- or Hyg, respectively, and transfectant-independent clones were estab-
v-abl-transformed cells, respectively (Yu et al., 1995; lished using a limiting dilution procedure. Expression of the chimeric
receptors was detected using a cell sorter (FACScan, BectonDickin-Daniel et al., 1995). STAT3 and STAT5 have also been
son), and the expression levels of Stat3F and Stat3D were analyzedshown to be constitutively activated in acute T cell leu-
by Northern blotting.kemia cells that had lost IL-2 dependency (Migone et
al., 1995). The targeted disruption of Stat4 and Stat6
Plasmid Constructiongenes in mice revealed that STAT4 and STAT6 are in-
To construct the chimeric receptor, we incorporated an EcoRI site
volved in growth signals in response to IL-12 and IL-4, into the amino-terminal side of the transmembrane domain of the
respectively (Kaplan et al., 1996a, 1996b; Shimoda et human G-CSFR cDNA in pEFBOS (Fukunaga et al., 1991; a gift
al., 1996; Takeda et al., 1996; Thierfelder et al., 1996). from Dr. Nagata) by PCR. The XbaI (derived from pEFBOS)–EcoRI
fragment was subcloned into pBluescript SK(1) (Stratagene). TheHere, we have definitively demonstrated that STAT3 is
transmembrane and cytoplasmic domains of human wild-type orinvolved in the growth signal by preventing apoptosis.
mutated gp130 were excised from the pSP72 containing them (Ya-These findings were verified by using chimeric receptors
manaka et al., 1996) by EcoRI and HindIII. The fragment was sub-
defective in the generation of STAT3 activation and the cloned into pBluescript containing the extracellular domain of the
dominant-negative Stat3 genes. The study reveals how G-CSFR. The fragments of chimeric receptors were excised by XbaI
STAT3 is involved in the process of cell proliferation. and cloned into the pEFBOS expression vector. The construction
of the dominant-negative STAT3F and STAT3D has been previouslyWe further demonstrated that STAT3 is involved in the
described (Nakajima et al., 1996).expression of bcl-2, an anti-apoptotic gene. We do not
know if the expression of bcl-2 is activated directly by
Immunoprecipitation, Immunoblotting, PeptideSTAT3 or whether there are intermediate processes.
Binding Assay, and Immunological ReagentsFurther promoter analysis using transfectants of the chi-
Cells (1 3 107) were harvested after stimulation and suspended with
meric receptors or the dominant-negative STAT3 will 1 ml of lysis buffer (1% NP-40, 20 mM Tris–HCl [pH 7.4], 150 mM
reveal the precise mechanisms. In any case, STAT3 is NaCl, 1 mM sodium vanadate,5 mg/ml aprotinin, and 5 mg/ml leupep-
tin). Lysates were cleared by a 10,000 3 g ultracentrifugation at 48Cessential for gp130-mediated anti-apoptotic signals. In
for 30 min and mixed with 10 ml of protein A–Sepharose (Pharmacia)addition to anti-apoptotic signals, we do not exclude
and 3 ml of anti-SHP-2, anti-SHP-1, anti-gp130, or anti-STAT3 anti-thepossible role of STAT3 in mitogenesis, including DNA
bodies, followed by an 8 hr incubation at 48C. The beads weresynthesis and progression of the cell cycle, although at
washed five times with 1 ml of the lysis buffer in the absence of
the moment we cannot evaluate this possibility because protease inhibitors. The immunoprecipitates were eluted with
cells with either the chimeric receptor lacking STAT3 Laemmli’s SDS loading buffer, separated on a 4%–20% SDS–
polyacrylamide gradient gel, and transferred to a PVDF membraneactivation or the dominant-negative STAT3 immediately
Immobilon P (Millipore). The membranes were incubated with eitherunderwent apoptosis before proceeding to mitogenesis,
1:2000 diluted anti-SHP-2 antibody, 1:2000 diluted anti-SHP-1 anti-even in the presence of the cytokines.
body, 1:2000 diluted anti-STAT3 antibody, or 0.1 mg/ml anti-phos-We previously demonstrated that STAT3 is involved
photyrosine antibody (4G10) for 1 hr at room temperature, washed
in the differentiation and growth arrest of mouse leuke- three times with TBST (20 mM Tris–HCl [pH 7.4], 150 mM NaCl,
mia M1 cells, but not in cell growth (Yamanaka et al., 0.1% Tween 20), and then incubated with 1:2000 diluted horseradish
peroxidase–conjugated goat anti-rabbit or anti-mouse antibodies1996; Nakajima et al., 1996). M1 cells can be maintained
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(TAGO). The immune complexwas visualized using a chemilumines- Ministry of Education, Science, Sports, and Culture in Japan, the
Yamanouchi Foundation for Research on Metabolic Disorders, andcence system (Renaissance, DuPont New England Nuclear). The
peptide binding assay was performed by mixing 5 mg of biotinylated the Osaka Foundation for Promotion of Clinical Immunology.
peptides and lysates derived from 1 3 107 transfectant cells. The
bound fraction was recovered with 10 ml of streptavidin–agarose Received July 15, 1996; revised October 4, 1996.
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